Provided by Tiger Trade Technology Pte. Ltd.

iRadimed

87.87
+0.69000.79%
Post-market: 87.870.00000.00%16:10 EDT
Volume:88.00K
Turnover:7.76M
Market Cap:1.12B
PE:49.09
High:89.13
Open:87.29
Low:85.74
Close:87.18
52wk High:107.90
52wk Low:67.84
Shares:12.79M
Float Shares:8.31M
Volume Ratio:1.08
T/O Rate:1.06%
Dividend:0.77
Dividend Rate:0.88%
EPS(TTM):1.79
EPS(LYR):1.75
ROE:23.52%
ROA:15.56%
PB:11.04
PE(LYR):50.21

Loading ...

iRadimed 2Q Revenue Rises as New Pump Launch Begins

Dow Jones
·
Aug 22

Integer Holdings Q2 Sales Fall 2.6%; KKR to Buy Company for $5.7 Billion

Reuters
·
Aug 03

IRadimed Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

IRadimed Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook, Reaffirms 2026 Guidance

MT Newswires Live
·
Jul 31

IRadimed Q2 Profit Rises on Record Monitor Bookings

Reuters
·
Jul 31

iRadimed Q2 Adj. EPS $0.46 Beats $0.42 Estimate, Sales $20.466M Beat $20.350M Estimate

Benzinga Earnings
·
Jul 31

GUIDANCE: (IRMD) IRadimed Expects 2026 Revenue Range $91M to $96M, vs. FactSet Est of $91.2M

MT Newswires Live
·
Jul 31

GUIDANCE: (IRMD) Iradimed Expects 2026 Adjusted EPS Range $2.09 to $2.24, vs. FactSet Est of $2.08

MT Newswires Live
·
Jul 31

IRadimed Q2 FY26 GAAP Diluted EPS Drops 9% to $0.41; Revenue Rises 0.5% to $20.5 Million

Reuters
·
Jul 31

IRadimed Corp: Continue to Gain Efficiencies, Which We Expect Will be Reflected in a Higher Gross Margin in Second Half of Year

THOMSON REUTERS
·
Jul 31

IRadimed Corp - Sees Q3 2026 Revenue $23 Mln-$24.50 Mln, Non-Gaap Diluted EPS $0.54-$0.59

THOMSON REUTERS
·
Jul 31

IRadimed Corporation Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 31

IRadimed Q2 EPS USD 0.41

THOMSON REUTERS
·
Jul 31

IRadimed Q2 Revenue USD 20.5 Million

THOMSON REUTERS
·
Jul 31

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 31

Record Results, New MRI Pump And Dividend Hike Might Change The Case For Investing In IRADIMED (IRMD)

Simply Wall St.
·
Jul 29

Iradimed Schedules Conference Call to Discuss Second-quarter 2026 Results

Reuters
·
Jul 25

Iradimed Shareholders Elect Five Directors at Annual Meeting

Reuters
·
Jun 24

Independent Director Hilda Scharen-Guivel Sold A Bunch Of Shares In IRADIMED

Simply Wall St.
·
Jun 07

IRadimed Director Hilda Scharen-Guivel disposes of 3,000 common shares for $285,000

Reuters
·
Jun 05